WNT9A and colorectal carcinoma: The results show that LiCl-mediated inhibition of CRC cell proliferation was reversed significantly in all cell lines by the specific Wnt9A antibody (p < 0.005; Figure 4C), whereas there was no effect elicited by an isotype-matched, control IgG.